
Talking Back To Ritalin
Peter Breggin(Author)
Da Capo Press Inc
Published on 17. September 2001
Book
Paperback/Softback
448 pages
978-0-7382-0544-1 (ISBN)
Description
Millions of children take Ritalin for Attention-Deficit Hyperactivity Disorder. The drug's manufacturer, Novartis, claims that Ritalin is the "solution" to this widespread problem. But hidden behind the well-oiled public-relations machine is a potentially devastating reality: children are being given a drug that can cause the same bad effects as amphetamine and cocaine, including behavioural disorders, growth suppression, neurological tics, agitation, addiction, and psychosis. Talking Back to Ritalin uncovers these and other startling facts and translates the research findings for parents and doctors alike. An advocate for education not medication, Dr. Breggin empowers parents to channel distracted, disenchanted, and energetic children into powerful, confident, and brilliant members of the family and society.
More details
Language
English
Place of publication
United States
Publishing group
Hachette Books
Target group
Professional and scholarly
Product notice
Paperback (UK-trade)
Dimensions
Height: 229 mm
Width: 152 mm
Thickness: 26 mm
Weight
722 gr
ISBN-13
978-0-7382-0544-1 (9780738205441)
Copyright in bibliographic data and cover images is held by Nielsen Book Services Limited or by the publishers or by their respective licensors: all rights reserved.
Schweitzer Classification
Other editions
Previous edition
Peter Roger Breggin | Ginger Ross Breggin
Talking Back to Ritalin
What Doctors Aren't Telling You About Stimulants for Children
Book
02/1998
Common Courage Press,U.S.
€43.51
No shipping information available
Person
Peter R. Breggin, M.D., is the author of a dozen books, including Talking Back to Prozac and The Antidepressant Factbook. He lives in Ithaca, New York.